Prognostic significance of blood-based multi-cancer detection in plasma cell-free DNA

Clin Chem Lab Med. 2021 Dec 30;60(3):88-89. doi: 10.1515/cclm-2021-1113. Print 2022 Feb 23.

Authors

Oscar D Pons-Belda¹, Amaia Fernandez-Uriarte¹, Annie Ren¹, Eleftherios P Diamandis^{1

2

3}

Affiliations

¹ Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada.
² Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
³ Department of Clinical Biochemistry, University Health Network, Toronto, ON, Canada.

PMID: 34964568
DOI: 10.1515/cclm-2021-1113

No abstract available

Keywords: cancer; cancer detection; cell-free DNA; prognosis; sensitivity; tumor size.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers, Tumor / blood
Biomarkers, Tumor / genetics
Cell-Free Nucleic Acids*
DNA, Neoplasm / blood
DNA, Neoplasm / genetics
Humans
Neoplasms* / diagnosis
Neoplasms* / genetics
Prognosis

Substances

Biomarkers, Tumor
Cell-Free Nucleic Acids
DNA, Neoplasm